EUVIMEDEUVIMED entdecken
Crossref

Systematic solutions for the treatment of AL amyloidosis: standardization of recording, improvement of diagnosis, patient pathways and medical education as the basis for care quality

H.L. Julhakyan, T.Ts. Garmaeva, M.V. Soloviev, L.V. Plastinina, I.G. Rekhtina, L.P. Mendeleyeva

Medical Technologies. Assessment and Choice · 26.06.2026 · 48 (2) · 139

DOI: 10.17116/medtech202648021139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Technologies. Assessment and Choice, erschienen am 26.06.2026. Verfasst von H.L. Julhakyan und 5 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To characterize care to patients with AL amyloidosis in accordance with current regulations, to analyze survey data from medical specialists on modern care and to identify current issues in medical education regarding diagnosis and treatment of patients with paraproteinemic hemoblastosis. Material and methods. We analyzed regulatory documents and problematic issues in organization of care for patients with AL amyloidosis taking into account expert assessments from chief hematologists in constituent entities of the Russian Federation. Specialists in care for patients with AL amyloidosis were surveyed.

Results

Regulatory acts governing care to patients with AL amyloidosis and status of hematologists as primary specialists for pathogenetic therapy were identified. Patient pathways issues were identified, and potential solutions were proposed (creation of regional regulatory documents regulating patient pathways to receive high-quality care). Survey of specialists identified the need for advanced professional program on organization of care, diagnosis and treatment of patients with AL amyloidosis.

Conclusion

Improved treatment of patients with AL amyloidosis is possible in case of state funding for expensive diagnosis and therapy. Correct coding of AL amyloidosis cases will enable organization of a patient registry and outcome monitoring, reduce the period between diagnosis and treatment, as well as facilitate patient pathways. It is necessary to develop and implement advanced educational programs for diagnosis and treatment of AL amyloidosis with practice-oriented training for hematologists, pathologists, and specialists in laboratory testing. Multidisciplinary teams, including hematologist, nephrologist and cardiologist, should be formed to ensure timely diagnosis and treatment, including pathogenetic antitumor targeted therapy.

Zitieren

APA

Julhakyan, H., Garmaeva, T., Soloviev, M., Plastinina, L., Rekhtina, I., & Mendeleyeva, L. (2026). Systematic solutions for the treatment of AL amyloidosis: standardization of recording, improvement of diagnosis, patient pathways and medical education as the basis for care quality. Medical Technologies. Assessment and Choice, 48(2), 139. https://doi.org/10.17116/medtech202648021139

Vancouver

Julhakyan H, Garmaeva T, Soloviev M, Plastinina L, Rekhtina I, Mendeleyeva L. Systematic solutions for the treatment of AL amyloidosis: standardization of recording, improvement of diagnosis, patient pathways and medical education as the basis for care quality. Medical Technologies. Assessment and Choice. 2026;48(2):139. doi:10.17116/medtech202648021139

BibTeX
@article{Julhakyan2026,
  author = {Julhakyan, H.L. and Garmaeva, T.Ts. and Soloviev, M.V. and Plastinina, L.V. and Rekhtina, I.G. and Mendeleyeva, L.P.},
  title = {Systematic solutions for the treatment of AL amyloidosis: standardization of recording, improvement of diagnosis, patient pathways and medical education as the basis for care quality},
  journal = {Medical Technologies. Assessment and Choice},
  year = {2026},
  volume = {48},
  number = {2},
  pages = {139},
  doi = {10.17116/medtech202648021139}
}
Kostenlos starten →